Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients

Joseph Farinella, Lauren M Granat, Hong Li, Sharon M Caroniti, Pranay S. Hegde, Matt Kalaycio, Ronald Sobecks, Claudio Brunstein, Craig S Sauter, Betty K. Hamilton

Blood (2023) 142 (Supplement 1): 3725.

https://doi.org/10.1182/blood-2023-189629

Published: 2023

Journal Articles

Racial Disparity in Hematopoietic Stem Cell Transplant Clinical Trial Recruitment

Akshee Batra, Rohit Singh, Saloni Savani, Diego Adrianzen Herrera, Atulya Aman Khosla, Claudio Brunstein

Blood (2023) 142 (Supplement 1): 3694.

https://doi.org/10.1182/blood-2023-178463

Published: 2023

Journal Articles

Influence of Pre-Transplant Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Ronald Sobecks, Hong Li, Danielle Cenin, Seema Patel, Jesse Edwards, Stephanie Farlow, Amelia Bragg, Rabi Hanna, Seth J Rotz, Deepa Jagadeesh, Aaron T. Gerds, Robert M. Dean, Brad Pohlman, Betty K. Hamilton, Claudio Brunstein, Matt Kalaycio, Craig S Sauter

Blood (2023) 142 (Supplement 1): 3621.

https://doi.org/10.1182/blood-2023-187071

Published: 2023

Journal Articles

Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Treated with CAR T-Cell Therapies

Agrima Mian, Danai Dima, Betty K. Hamilton, Allison Winter, Jack Khouri, Louis S. Williams, Shahzad Raza, Deepa Jagadeesh, Aaron T. Gerds, Robert M. Dean, Matt Kalaycio, Claudio Brunstein, Craig S Sauter, Faiz Anwer, Brian T. Hill, Paolo Caimi

Blood (2023) 142 (Supplement 1): 7399.

https://doi.org/10.1182/blood-2023-188712

Published: 2023

Journal Articles

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

Blood (2022) 139 (8): 1177–1183.

https://doi.org/10.1182/blood.2021011532

Published: 2022

Includes: Supplemental data

Journal Articles

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

Blood (2021) 138 (16): 1429–1440.

https://doi.org/10.1182/blood.2021011719

Published: 2021

Includes: Supplemental data

Journal Articles

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

Rohtesh S. Mehta, MD MPH, MS, Nelli Bejanyan, MD, Qing Cao, M.S., Xianghua Luo, PhD, Claudio Brunstein, Sarah Cooley, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 2246.

https://doi.org/10.1182/blood.V128.22.2246.2246

Published: 2016

Journal Articles

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

Mayada Salman Abu Shanap, MD, Sarah Cooley, MD, Xianghua Luo, PhD, Cao Qing, Julie Curtsinger, PhD, Rachel Bergerson, PhD, Nelli Bejanyan, Heather Stefanski, MD PhD, Claudio Brunstein, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E Wagner, MD, Michael R. Verneris, MD

Blood (2015) 126 (23): 1934.

https://doi.org/10.1182/blood.V126.23.1934.1934

Published: 2015

Journal Articles

CMV Reactivation is Associated with Reduced Relapse Risk, Better Disease-Free Survival and Expansion of Adaptive NK Cells after Reduced Intensity Hematopoietic Cell Transplantation

Frank Cichocki, PhD, Zachary B. Davis, PhD, Todd E. DeFor, MS, Sarah A. Cooley, MD MS, Yenan T. Bryceson, PhD, Don J. Diamond, PhD, Bruce R. Blazar, MD, Claudio Brunstein, MD, John E. Wagner, MD, Michael R. Verneris, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2014) 124 (21): 668.

https://doi.org/10.1182/blood.V124.21.668.668

Published: 2014

Journal Articles

StemRegenin-1 (SR1) Expansion Culture Abrogates the Engraftment Barrier Associated with Umbilical Cord Blood Transplantation (UCBT)

John E Wagner, MD, Claudio Brunstein, MD, David McKenna, MD, Darin Sumstad, MT(ASCP), Suzanne Maahs, Mary Laughlin, MD, Michael S. Perry, DVM,PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, Conrad C. Bleul, MD

Blood (2014) 124 (21): 728.

https://doi.org/10.1182/blood.V124.21.728.728

Published: 2014

Journal Articles

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Zachary B. Davis, PhD, Frank Cichocki, PhD, Martin Felices, PhD, Rose Wangen, Todd E. DeFor, MS, Sarah A. Cooley, MD MS, Yenan T. Bryceson, PhD, Don J. Diamond, PhD, Claudio Brunstein, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Amir Horowitz, Lisbeth A Guethlein, Peter Parham, PhD, Michael R. Verneris, MD, Jeffrey S. Miller, MD

Blood (2014) 124 (21): 181.

https://doi.org/10.1182/blood.V124.21.181.181

Published: 2014

Journal Articles

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Aleksandr Lazaryan, MD PhD MPH, Todd E. DeFor, MS, Claudio Brunstein, MD, Margaret L. MacMillan, MD, Nelli Bejanyan, MD, Shernan G. Holtan, MD, Bruce R. Blazar, MD, John E Wagner, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 189.

https://doi.org/10.1182/blood.V124.21.189.189

Published: 2014

Journal Articles

Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse

Rachel Joy Bergerson, PhD, Sarah Cooley, MD, Julie Curtsinger, PhD, Ryan Shanley, Claudio Brunstein, MD, Bruce R Blazar, MD, John E. Wagner, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2013) 122 (21): 4610.

https://doi.org/10.1182/blood.V122.21.4610.4610

Published: 2013

Journal Articles

Phosphoramide Mustard As a Biomarker Of Cyclophosphamide Exposure In Adults Receiving Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Anthony C. Wiseman, BS, Sanghavi Kinjal, BS, MS, Claudio Brunstein, MD, Erica D. Warlick, MD, Daniel J. Weisdorf, MD, Qing Cao, MS, John Rogosheske, PharmD, Pamala A. Jacobson

Blood (2013) 122 (21): 5461.

https://doi.org/10.1182/blood.V122.21.5461.5461

Published: 2013

Journal Articles

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Veronika Bachanova, MD, Claudio Brunstein, MD, Linda J. Burns, MD, Tao Wang, PhD, Jeanette Carreras, MPH, Ginna G. Laport, MD, Sonali M. Smith, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Wael Saber, MD, MS

Blood (2013) 122 (21): 161.

https://doi.org/10.1182/blood.V122.21.161.161

Published: 2013

Journal Articles

Alternative Donor Hematopoietic Transplantation For Patients Older Than 50 Years With AML In First Complete Remission: Unrelated Donor and Umbilical Cord Blood Transplantation Outcomes

Daniel J. Weisdorf, MD, Mary Eapen, MBBS, MS, Annalisa Ruggeri, MD, Mei-Jie Zhang, PhD, Xiaobo Zhong, MS, Claudio Brunstein, MD, Celalettin Ustun, Vanderson Rocha, MD, Eliane Gluckman, MD

Blood (2013) 122 (21): 302.

https://doi.org/10.1182/blood.V122.21.302.302

Published: 2013

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) in Adult and Pediatric Acute Lymphoblastic Leukemia: Impact of Minimal Residual Disease on Relapse and Survival,

Veronika Bachanova, MD, Michael J Burke, MD, Claudio Brunstein, MD, Michael R Verneris, MD, Qing Cao, MS, John E. Wagner, MD, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 4114.

https://doi.org/10.1182/blood.V118.21.4114.4114

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia

Betul Oran, MD, MS, Timothy Singleton, MD, Pablo A. Ramirez, MD, Ryan Shanley, MS, Claudio Brunstein, MD, Celalettin Ustun, MD, Erica D Warlick, MD, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 2027.

https://doi.org/10.1182/blood.V118.21.2027.2027

Published: 2011

Journal Articles

Elevated Absolute Lymphocyte Counts Following Acute Graft Vs. Host Disease Treatment Is Associated with Therapeutic Responses and Lower Non-Relapse Mortality Following Umbilical Cord Blood Transplant,

Michael R Verneris, MD, Sanyukta Janardan, BS, Michael J Burke, MD, Todd E. Defor, MS, Claudio Brunstein, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E. Wagner, MD, Daniel Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2011) 118 (21): 4085.

https://doi.org/10.1182/blood.V118.21.4085.4085

Published: 2011

Journal Articles

The Impact of Bone Marrow Hematogones on Umbilical Cord Blood Transplant Outcomes in Acute Myeloid Leukemia Patients,

Theodore Honebrink, MD, Vanessa J. Dayton, MD, Karen Larsen, MD, Qing Cao, MS, Claudio Brunstein, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD, John E. Wagner, MD, Michael R Verneris, MD

Blood (2011) 118 (21): 4148.

https://doi.org/10.1182/blood.V118.21.4148.4148

Published: 2011

NARROW

Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients

Racial Disparity in Hematopoietic Stem Cell Transplant Clinical Trial Recruitment

Influence of Pre-Transplant Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Treated with CAR T-Cell Therapies

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT)

CMV Reactivation is Associated with Reduced Relapse Risk, Better Disease-Free Survival and Expansion of Adaptive NK Cells after Reduced Intensity Hematopoietic Cell Transplantation

StemRegenin-1 (SR1) Expansion Culture Abrogates the Engraftment Barrier Associated with Umbilical Cord Blood Transplantation (UCBT)

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Early NK Cell Proliferation After Umbilical Cord Blood Transplantation Is Associated With Superior Disease-Free Survival Due To Reduced Leukemia Relapse

Phosphoramide Mustard As a Biomarker Of Cyclophosphamide Exposure In Adults Receiving Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Alternative Donor Hematopoietic Transplantation For Patients Older Than 50 Years With AML In First Complete Remission: Unrelated Donor and Umbilical Cord Blood Transplantation Outcomes

Unrelated Cord Blood Transplantation (UCBT) in Adult and Pediatric Acute Lymphoblastic Leukemia: Impact of Minimal Residual Disease on Relapse and Survival,

Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia

Elevated Absolute Lymphocyte Counts Following Acute Graft Vs. Host Disease Treatment Is Associated with Therapeutic Responses and Lower Non-Relapse Mortality Following Umbilical Cord Blood Transplant,

The Impact of Bone Marrow Hematogones on Umbilical Cord Blood Transplant Outcomes in Acute Myeloid Leukemia Patients,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only